Peter Stephen Conti

Peter Stephen Conti, MD, PhD, is a tenured Professor at the University of Southern California (USC) with academic appointments in Radiology, Biomedical Engineering, and Pharmacology and Pharmaceutical Sciences. He serves as Director of the Molecular Imaging Center and Associate Chief of Nuclear Medicine. His research focuses on molecular imaging, particularly the development of PET and hybrid imaging agents for cancer and other diseases. Conti has authored over 300 peer-reviewed publications and received multiple awards, including the Paul C Aebersold Award (2016), Peter Valk Award (2018), and the Benedict Cassen Prize (2020). His work spans theranostics, diagnostic advancements, and translational research in nuclear medicine.

Education: Undergraduate degree from Johns Hopkins University, medical degree from Cornell University, PhD in Biophysics from Memorial Sloan-Kettering Cancer Center.

Research Interests: Molecular imaging technologies, PET agent development, cancer diagnostics, theranostics, and clinical applications of nuclear medicine. Key areas include imaging tumor biology, radiopharmaceuticals, and multimodal imaging strategies.

Articles Overview: Recent publications highlight advancements in PET-guided radiotherapy, fasting mimicking diets, and nanoparticle-based imaging. His work often bridges basic science and clinical translation, emphasizing diagnostic accuracy and therapeutic monitoring.

Awards: Recognitions include the Aebersold Award for basic nuclear medicine science, Valk Award for clinical PET contributions, and the Cassen Prize for pioneering radiopharmaceutical development and service to the molecular imaging community.

Labs/Teams: Leads the USC PET Imaging Science Center, established in 1991, and collaborates on multidisciplinary teams advancing molecular imaging and theranostics.